- Home
- TCBP
as 07-26-2024 4:00pm EST
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | HOLYTOWN |
| Market Cap: | 4.1M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 50.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -19.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.72 - $196.00 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest TC BioPharm (Holdings) plc News
TCBP Breaking Stock News: Dive into TCBP Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
TC BioPharm Doses Sixth Person in TCB-008 Trial for Acute Myeloid Leukemia Treatment
PR Newswire
4 days ago
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia
PR Newswire
2 months ago
TCBP Announces Launch of Compassionate Use Program for TCB008
PR Newswire
3 months ago
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
PR Newswire
3 months ago
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
PR Newswire
4 months ago
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
PR Newswire
4 months ago
TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
PR Newswire
4 months ago
TCBP Adjourns General Meeting Until a Later Date
Compare TCBP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TCBP TC BioPharm (Holdings) plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.